Elderly frailty may change how muscle relaxants work during surgery

NCT ID NCT07580144

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study looks at whether sarcopenia (muscle loss) and frailty affect how the muscle relaxant rocuronium works in older patients having surgery. Researchers will monitor 100 adults aged 65 and older to see how fast the drug takes effect and how long it lasts. The goal is to help doctors give safer anesthesia doses to frail elderly patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

rocuronium

What this could lead to

If successful, this could help anesthesiologists adjust rocuronium doses for frail or sarcopenic elderly patients, improving safety during surgery.

What could go wrong

This is an observational study, not a treatment trial. It only measures effects without testing a new drug or intervention, so direct patient benefits are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FRAILTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Betul Kozanhan

    RECRUITING

    Konya, 42005, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••